Video Experimental Relacionado
Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Manifestaciones Clínicas
Angélica Zuno-Reyes1, Karina Pérez-Rubio1, Ricardo Jáuregui Torres1
1Instituto de Neurociencias, CUCBA, Universidad de Guadalajara, Guadalajara, JA, Mexico.
Background:
We aimed to assess memory and executive functions (EF) performance in preclinical carriers (PC) of APPV717I autosomal dominant Alzheimer's disease (ADAD) and to know if age and years of schooling (YoS) affect their results.
Method:
Our research included fifteen PC (Mage = 37.27 years, standard deviation [SD] = 6.82; MYoS = 10.07 years, SD = 4.10) and twenty-four non-carriers (NC; Mage = 32.17 years, SD = 10.95; MYoS = 9.08, SD = 2.92) of APPV717I, all of them directly family related. We assessed PC and NC groups in a small town in Jalisco, Mexico. All the participants obtained a Clinical Dementia Rating (CDR) score of zero. The EF and memory tasks are included in the Mexican standardization of the neuropsychological protocol from the Consortium to Establish a Registry for Alzheimer's Disease and its complementary tasks (CERAD-MX; Zuno-Reyes et al., 2023). We compared PC and NC scores with t-tests. Finally, we analyzed age and YoS effects through correlations and linear regressions in those comparisons with medium or large effect sizes.
Result:
PC obtained fewer Conceptual Level Responses (CLR; M = 16.73, SD = 6.11) than NC (M = 22.04, SD = 10.04) on the MWCST. As for the memory tasks, we found similar scores in both PC and NC. Age did not predict this outcome (b = -.33, r2 = .14, p = .175) but showed a moderate negative correlation (r = -.37, p = .175). YoS yielded a strong positive correlation (r = .60, p = .018) and predicted this result (b = .90, r2 = .31, p = .018).
Conclusion:
While memory problems are frequently reported in preclinical carriers of other ADAD mutations, our PC- APPV717I and NC groups scored similarly on memory tasks. However, we found preclinical difficulties in the MWCST, which assesses cognitive flexibility. YoS is positively correlated and predicts this result. To our knowledge, no published studies report preclinical EF performance in any of the APP mutations, so our work marks a precedent in exploring EF in APPV717I through this stage, being this the most frequently identified APP mutation worldwide.
Más Videos Relacionados
Videos de Conceptos Relacionados
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Endocarditis II: Clinical Features of Infective Endocarditis
Heart Failure III: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Hypertension III: Clinical Manifestations and Diagnostic Studies

